BioCentury
ARTICLE | Company News

Ferrer, Venter Pharma S.L. deal

March 17, 2014 7:00 AM UTC

Ferrer will acquire an 18% stake in Venter Pharma for €3.5 million ($4.9 million), including an initial €1.3 million ($1.7 million) payment. The deal, which has been approved by the boards of both companies, includes existing shares from current shareholders as well as a new equity offering. As part of the deal, Ferrer will nominate a director to Venter's board. Venter directed questions to Ferrer, which could not be reached for details. ...